Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUDYSA: Impact of Sarcopenia on Dyspnea in Asthma
NCT06870890Not yet recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Mar 2025
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Variation in the intensity of dyspnea during exercise. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06870890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06870890.